Cardio Diagnostics Holdings, Inc.(CDIO)

Biotechnology · Chicago, IL

$2.02-0.04 (-1.94%)

Delayed quote: Oct 6, 2026, 12:10 PM EDT

Cardio Diagnostics Holdings (CDIO) EV/FCF: History & Chart | TGMCharts

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T16:16:06.515Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:16:06.515Z.

Quote observation: 2026-10-06T16:13:26.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 6,066,911
Total debt · period ending 2026-06-30: 369,698
Cash · period ending 2026-06-30: 5,586,697
TTM free cash flow · period ending 2026-06-30: -5,841,460

FMP input reference: 9b4bc62a31f75b1a016fc6ea0dc71fcb65437a541a8d62a03c8decabfd044c64

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CDIO EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

CDIO Competitors' EV/FCF Ratio

CDIO

Cardio Diagnostics Holdings, Inc.

Current

Market Cap

$6.07M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENLV

Enlivex Therapeutics Ltd.

vs CDIO

Market Cap

$5.98M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCNX

Scienture Holdings, Inc.

vs CDIO

Market Cap

$5.91M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCY

Lucyd, Inc

vs CDIO

Market Cap

$5.85M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FEMY

Femasys Inc.

vs CDIO

Market Cap

$6.16M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACXP

Acurx Pharmaceuticals, Inc.

vs CDIO

Market Cap

$5.72M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs CDIO

Market Cap

$5.77M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVNO

enVVeno Medical Corporation

vs CDIO

Market Cap

$5.60M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMRA

Biomerica, Inc.

vs CDIO

Market Cap

$6.54M

EV/FCF Ratio

N/A

TTM Avg

126.41x

3Y Avg

126.41x

5Y Avg

126.41x

ENSC

Ensysce Biosciences, Inc.

vs CDIO

Market Cap

$6.43M

EV/FCF Ratio

N/A

TTM Avg

1251.36x

3Y Avg

3596.80x

5Y Avg

3596.80x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Cardio Diagnostics Holdings, Inc. (CDIO)	$6.07M	N/A	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$5.98M	N/A	N/A	N/A	N/A
Scienture Holdings, Inc. (SCNX)vs ›	$5.91M	N/A	N/A	N/A	N/A
Lucyd, Inc (LUCY)vs ›	$5.85M	N/A	N/A	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.16M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.72M	N/A	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.77M	N/A	N/A	N/A	N/A
enVVeno Medical Corporation (NVNO)vs ›	$5.60M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.54M	N/A	126.41x	126.41x	126.41x
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.43M	N/A	1251.36x	3596.80x	3596.80x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

CDIO EV/FCF Ratio Metrics

CDIO Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics